/C O R R E C T I O N -- China Sky One Medical, Inc./
China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
HARBIN, China, Nov. 4 /Xinhua-PRNewswire-FirstCall/ -- China Sky OneMedical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), aleading fully integrated pharmaceutical company producing over-the-counterdrugs in the People's Republic of China ("PRC"), today announced that it willconduct a conference call at 9:00 A.M. Eastern Time on November 10, 2008 todiscuss its third quarter 2008 financial results.
Joining Mr. Yan-qing Liu, Chairman, CEO and Director of China Sky OneMedical, Inc., will be Yu-bo Hao, Board Secretary. The Company plans to issuean earnings announcement prior to the call.
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time: (866)573-1052. International callers should dial (702) 696-4500. The ConferenceID for this call is 72520119.
If you are unable to participate in the call at this time, a replay willbe available for fourteen days starting on Monday, November 10, 2008 at 12 P.M.Eastern Time. To access the replay, dial (800) 642-1687, internationalcallers dial (706) 645-9291 Conference ID 72520119
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company.The Company engages in the manufacturing, marketing and distribution ofpharmaceutical, medicinal and diagnostic products. Through its wholly-ownedsubsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR")and Harbin First Bio- Engineering Company Limited ("First"), the Companymanufactures and distributes over-the-counter pharmaceutical products, whichmake up its major revenue source. For more information, visithttp://www.skyonemedical.com .
Safe Harbor Statement
Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities LitigationReform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should,""project," "plan," "seek," "intend," or "anticipate" or the negative thereofor comparable terminology. Such statements typically involve risks anduncertainties and may include financial projections or information regardingour future plans, objectives or performance. Actual results could differmaterially from the expectations reflected in such forward-looking statementsas a result of a variety of factors, including the risks associated with theeffect of changing economic conditions in The People's Republic of China,variations in cash flow, reliance on collaborative retail partners and on newproduct development, variations in new product development, risks associatedwith rapid technological change, and the potential of introduced or undetectedflaws and defects in products, and other risk factors detailed in reportsfiled with the Securities and Exchange Commission from time to time.For more information, please contact: Company Contact: China Sky One Medical, Inc. Mr. Yu-bo Hao, Board Secretary Tel: +86-0451-53994069 Email: email@example.com Investor Relations Contact: CCG Investor Relations Mr. Crocker Coulson, President Tel: +1-646-213-1915 Email: firstname.lastname@example.org Mr. Richard Micchelli, Financial Writer Tel: +1-646-454-4516 Email: email@example.com Web site: http://www.ccgirasia.com
SOURCE China Sky One Medical, Inc.
You May Also Like